What is Verogen?
Verogen is a prominent entity in the field of forensic science, offering a comprehensive suite of next-generation sequencing (NGS) products. Their offerings encompass kits, systems, and software meticulously designed to optimize laboratory workflows and support critical applications such as mitochondrial DNA analysis and kinship studies. By focusing on high-quality, integrated solutions, Verogen empowers law enforcement agencies and forensic laboratories with advanced tools to tackle complex DNA analysis challenges and achieve more effective outcomes in human identification.
How much funding has Verogen raised?
Verogen has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Verogen
PPP
Public-Private Partnership
What's next for Verogen?
With the recent strategic investment and substantial total funding, Verogen is poised for accelerated growth and innovation in the forensic technology sector. This capital will likely fuel further development of their NGS platforms, expand market reach, and enhance their capabilities in areas like mitochondrial DNA analysis. The company's focus on providing robust solutions for forensic investigations suggests a strategic direction aimed at solidifying its leadership in a critical and evolving market, potentially leading to broader adoption of advanced DNA analysis techniques in criminal justice and identification processes.
See full Verogen company page
